National/Regional Resource Core: Accelerating Health Equity And Eliminating Diabetes Disparities in Community Health Centers (AHEAD-CHC)

项目摘要--国家/区域资源核心 国家核心的总体目标是在社区中催化以公平为重点的糖尿病翻译研究 卫生中心(CHC)，为全美弱势人群提供护理的主要门诊系统。 拟议核心，题为《促进卫生公平和消除社区卫生中的糖尿病差距》 中心(AHEAD-CHC)，聘用了全国三个最大、最有能力的CHC网络组织： 联盟芝加哥(Alliance)、健康选择网络(HCN)和中西部临床医生网络(MWCN)。 这些组织总共支持美国29个州的246个CHC站点，为约750万人提供服务 病人。Ahead-CHC还将与临床主任网络(CDN)合作开展传播活动 面向所有50个州的相关利益攸关方的全国受众。Ahead-CHC利用以下优势 现有资产和关键基础设施，以成功实现这一国家核心的目标。在目标1中， Alliance和HCN将扩展现有的国家糖尿病数据库，该数据库目前包括100多万 ，并将此资源提供给全国糖尿病翻译研究人员和 CHC临床医生提供以股票为重点的分析。在AIM 2中，Alliance、HCN和MWCN将提供一系列咨询服务 支持糖尿病研究人员与CHC配对合作的服务，并帮助催化成功 这些小组以实践为基础的研究。具体地说，Ahead-CHC合作伙伴将利用现有基础设施 提供咨询，参加会议，并提供分析支持，以加快新糖尿病的翻译 在他们的CHC网络中进行的研究。在目标3中，Ahead-CHC提供了一个由以下人员领导的国家传播机构 CDN将利用其现有的50,000多名研究人员、CHC工作人员和其他利益相关者 以核心支持的糖尿病研究为主题的网络研讨会系列。CDN随后将把网络研讨会归档到 Ahead-CHC网站，以及相关的研究产品(例如，同行评议的出版物， 干预协议和白皮书)，以便可以无限制地按需访问这些材料 观众。具有在CHC进行高影响力糖尿病研究的丰富集体经验，然后 将研究结果转化为改善糖尿病的护理和结果，Ahead-CHC领导团队的成员 是这一领域的国家当局，他们在拟议的工作中具有得天独厚的地位。前进--CHC 通过以下方式高度响应RFA-DK-20-002：1)重点关注脆弱、高危人群的健康公平 由CHC服务的人群；2)提供资源和服务，促进整个研究的工作 从建立伙伴关系到将研究成果转化为实践和政策的连续过程；3)加强 通过集中这些不同的资产并从以下位置提供它们来提高效率、生产力和效力 单一接入点；以及4)展示芝加哥糖尿病中心之外的既定覆盖范围 翻译研究到美国所有50个州。

PROJECT SUMMARY - National/Regional Resource Core The overall goal of the national core is to catalyze equity-focused diabetes translation research in community health centers (CHC), the primary ambulatory system of care for vulnerable populations across the U.S. The proposed core, entitled Accelerating Health Equity And Eliminating Diabetes Disparities in Community Health Centers (AHEAD-CHC), engages three of the largest and most capable CHC network organizations nationwide: AllianceChicago (Alliance), Health Choice Network (HCN), and MidWest Clinicians' Network (MWCN). Collectively, these organizations support a total of 246 CHC sites across 29 U.S. states serving ~7.5 million patients. AHEAD-CHC will also partner with Clinical Directors Network (CDN) for dissemination activities reaching a national audience of relevant stakeholders in all 50 states. AHEAD-CHC leverages the following existing assets and critical infrastructure to accomplish the aims of this national Core successfully. In Aim 1, Alliance and HCN will expand an existing National Diabetes Data Repository that currently includes over 1 million CHC patients, and make this resource available to a national audience of diabetes translation researchers and CHC clinicians for equity-focused analyses. In Aim 2, Alliance, HCN, and MWCN will offer a range of consultative services to support collaborations pairing diabetes investigators with CHCs, and help catalyze successful practice-based research by these groups. Specifically, AHEAD-CHC partners will leverage existing infrastructure to offer consultations, participate in meetings, and provide analytic support to accelerate new diabetes translation research conducted in their CHC networks. In Aim 3, AHEAD-CHC offers a national dissemination arm led by CDN, which will leverage its existing audience of over 50,000 researchers, CHC staff, and other stakeholders for a webinar series featuring diabetes research supported by the Core. CDN will then archive the webinars on the AHEAD-CHC website, along with associated research products (e.g. peer-reviewed publications, intervention protocols, and white papers), so that these materials can be accessed on demand by an unlimited audience. With extensive collective experience conducting high-impact diabetes research in CHCs and then translating findings into improved diabetes care and outcomes, members of the AHEAD-CHC leadership team are national authorities in this area, who are uniquely positioned to succeed in the proposed work. AHEAD-CHC is highly responsive to RFA-DK-20-002 by: 1) focusing on health equity among the vulnerable, high-risk populations served by CHCs; 2) offering resources and services that catalyze work across the research continuum from partnership building to translation of research products into practice and policy; 3) enhancing efficiency, productivity, and effectiveness by centralizing these diverse assets and making them available from a single access point; and 4) demonstrating established reach beyond the Chicago Center for Diabetes Translation Research into all 50 U.S. states.